OrthoPediatrics KIDS Payments To Acquire Private Companies And Licenses
Payments To Acquire Private Companies And Licenses at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept kids:PaymentsToAcquirePrivateCompaniesAndLicenses.
The official record: OrthoPediatrics’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's payments to acquire private companies and licenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OrthoPediatrics's payments to acquire private companies and licenses?
- OrthoPediatrics (KIDS) reported payments to acquire private companies and licenses of $504.25K in Q4 2025.
- How has OrthoPediatrics's payments to acquire private companies and licenses changed year-over-year?
- OrthoPediatrics's payments to acquire private companies and licenses increased by 211.7% year-over-year, from $161.75K to $504.25K.
- What is the long-term trend for OrthoPediatrics's payments to acquire private companies and licenses?
- Over 2 years (2023 to 2025), OrthoPediatrics's payments to acquire private companies and licenses has grown at a -2.1% compound annual growth rate (CAGR), from $2.11M to $2.02M.
- What does payments to acquire private companies and licenses mean?
- Measures the cash deployed for the strategic acquisition of private entities, intellectual property, or exclusive product licenses. This reflects the company's inorganic growth strategy and its ability to expand its product portfolio through external innovation. High levels of spending here indicate an aggressive pursuit of market share or technological leadership in the pediatric orthopedic space.